U.S. & Europe Value-Based Healthcare (VBHC) Services Market Size, Share & Trends Analysis Report, By Models (Pay for performance, Patient-centered medical home, Shared savings, Shared risk, Bundled payment, Capitation models), By Payers Category (Medicare and Medicare Advantage, Medicaid, Commercial), By Provider's Utilization Category (Home Health Care, Institutional Care, Self-Care, Hospital Therapy), By Service Type, By Region, Forecasts, 2025-2034

Report Id: 1421 Pages: 180 Last Updated: 06 November 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of U.S. & Europe Value-Based Healthcare Services Market-

By Models-

·       Shared Savings Model

·       Capitation / Global Budget Model

·       Bundled Payment Model

·       Pay-for-Performance (P4P) Model

·       Patient-Centered Medical Home (PCMH)

·       Accountable Care Organization (ACO) Model

·       Others (Hybrid / Emerging Models)

 value based healthcare

By Service Type -

·       Care Coordination & Management Services

·       Population Health Management Services

·       Patient Engagement & Experience Services

·       Health Data Analytics & Outcome Measurement Services

·       Telehealth / Virtual Care Services

·       Post-Acute & Home Health Services

·       Consulting, Training & Implementation Services

By End-User / Stakeholder

·       Hospitals & Health Systems

·       Physician Groups / Clinics

·       Payers / Insurance Companies

·       Government & Public Health Agencies

·       Employer-Based Healthcare Programs

·       Telehealth & Digital Health Providers

By Region-

North America

·       United States

·       Canada

Europe

·       Germany

·       United Kingdom

·       France

·       Italy

·       Spain

  • Rest of Europe
 
 
 
 
 
 

Chapter 1.    Methodology and Scope

1.1.    Research Methodology
1.2.    Research Scope & Assumptions

Chapter 2.    Executive Summary

Chapter 3.    Global U.S. & Europe Value-Based Healthcare (VBHC) Services Market Snapshot

Chapter 4.    Global U.S. & Europe Value-Based Healthcare (VBHC) Services Market Variables, Trends & Scope

4.1.    Market Segmentation & Scope
4.2.    Drivers
4.3.    Challenges
4.4.    Trends
4.5.    Investment and Funding Analysis 
4.6.    Industry Analysis – Porter’s Five Forces Analysis
4.7.    Competitive Landscape & Market Share Analysis
4.8.    Impact of Covid-19 Analysis

Chapter 5.    Market Segmentation 1: by Model Estimates & Trend Analysis

5.1.    by Model & Market Share, 2024 & 2034
5.2.    Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Model:

5.2.1.    Shared Savings Model
5.2.2.    Capitation / Global Budget Model
5.2.3.    Bundled Payment Model
5.2.4.    Pay-for-Performance (P4P) Model
5.2.5.    Patient-Centered Medical Home (PCMH)
5.2.6.    Accountable Care Organization (ACO) Model
5.2.7.    Others (Hybrid / Emerging Models)

Chapter 6.    Market Segmentation 2: by Service Type Estimates & Trend Analysis

6.1.    by Service Type & Market Share, 2024 & 2034
6.2.    Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Service Type:

6.2.1.    Population Health Management Services
6.2.2.    Patient Engagement & Experience Services
6.2.3.    Health Data Analytics & Outcome Measurement Services
6.2.4.    Telehealth / Virtual Care Services
6.2.5.    Post-Acute & Home Health Services
6.2.6.    Consulting, Training & Implementation Services

Chapter 7.    Market Segmentation 3: by Platform Estimates & Trend Analysis

7.1.    by Platform & Market Share, 2024 & 2034
7.2.    Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Platform:

7.2.1.    Standalone
7.2.2.    Integrated

Chapter 8.    Market Segmentation 4: by Industry Vertical Estimates & Trend Analysis

8.1.    by Industry Vertical & Market Share, 2024 & 2034
8.2.    Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Industry Vertical:

8.2.1.    Providers (Hospitals, Clinics, Others)
8.2.2.    Payers (Insurance Companies, Government, Others)

Chapter 9.    U.S. & Europe Value-Based Healthcare (VBHC) Services Market Segmentation 5: Regional Estimates & Trend Analysis

9.1.    North America

9.1.1.    North America U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Model, 2021-2034
9.1.2.    North America U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
9.1.3.    North America U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Platform, 2021-2034
9.1.4.    North America U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Industry Vertical, 2021-2034
9.1.5.    North America U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

9.2.    Europe

9.2.1.    Europe U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Model, 2021-2034
9.2.2.    Europe U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
9.2.3.    Europe U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Platform, 2021-2034
9.2.4.    Europe U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Industry Vertical, 2021-2034
9.2.5.    Europe U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

9.3.    Asia Pacific

9.3.1.    Asia Pacific U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Model, 2021-2034
9.3.2.    Asia Pacific U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
9.3.3.    Asia-Pacific U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Platform, 2021-2034
9.3.4.    Asia-Pacific U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Industry Vertical, 2021-2034
9.3.5.    Asia Pacific U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

9.4.    Latin America

9.4.1.    Latin America U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Model, 2021-2034
9.4.2.    Latin America U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
9.4.3.    Latin America U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Platform, 2021-2034
9.4.4.    Latin America U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Industry Vertical, 2021-2034
9.4.5.    Latin America U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

9.5.    Middle East & Africa

9.5.1.    Middle East & Africa U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Model, 2021-2034
9.5.2.    Middle East & Africa U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Service Type, 2021-2034
9.5.3.    Middle East & Africa U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Platform, 2021-2034
9.5.4.    Middle East & Africa U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by Industry Vertical, 2021-2034
9.5.5.    Middle East & Africa U.S. & Europe Value-Based Healthcare (VBHC) Services Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

Chapter 10.    Competitive Landscape

10.1.    Major Mergers and Acquisitions/Strategic Alliances
10.2.    Company Profiles

10.2.1.    UnitedHealth Group (Optum)
10.2.2.    Humana Inc.
10.2.3.    CVS Health / Aetna
10.2.4.    Elevance Health (Anthem)
10.2.5.    Cigna / Evernorth
10.2.6.    Kaiser Permanente
10.2.7.    Agilon Health
10.2.8.    Aledade
10.2.9.    Lumeris
10.2.10.    Health Catalyst
10.2.11.    Privia Health
10.2.12.    Evolent Health
10.2.13.    Oak Street Health (CVS Health subsidiary)
10.2.14.    VillageMD
10.2.15.    ChenMed
10.2.16.    Signify Health, Inc.
10.2.17.    Stellar Health
10.2.18.    Curation Health (now part of Reveleer)
10.2.19.    Change Healthcare
10.2.20.    NXGN Management, LLC (NextGen Healthcare)
10.2.21.    Athenahealth, Inc.
10.2.22.    McKesson Corporation
10.2.23.    Koninklijke Philips N.V. (Philips Healthcare)
10.2.24.    Siemens Medical Solutions USA, Inc.
10.2.25.    Genpact
10.2.26.    Baker Tilly US, LLP
10.2.27.    Deloitte
10.2.28.    Epic Systems Corporation
10.2.29.    Intermountain Health
10.2.30.    Lumeris
10.2.31.    Veradigm (Allscripts)
10.2.32.    OthersOther Prominent Players

 

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
2996
Security Code field cannot be blank!

Frequently Asked Questions

U.S. Value-Based Healthcare Services Market Size is valued at USD 3.6 Billion in 2024 and is predicted to reach USD 8.1 Billion by the year 2034

U.S. Value-Based Healthcare Services Market is expected to grow at a 8.6% CAGR during the forecast period for 2025-2034

Athena Healthcare, Baker Tilly US, LLP, Boston Consulting Group, Change Healthcare, Curation Health, Deloitte, ForeSee Medical, Inc., Genpact, Humana,

By Models, By Service Type, By end user are the key segments of the U.S. value-based healthcare services market.

North America region is leading the U.S. Value-Based Healthcare Services Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying